Medical and Science
Beyond the protocol: How Icon Group is redefining clinical trials with heart
Sophie Mepham, Group Executive Manager of Research at Icon Group, invites us into the often unseen world where purpose and […]
MoreMedical and Science
World’s largest study to decode genetic roots of eating disorders
Researchers from QIMR Berghofer and the InsideOut Institute have launched the world’s largest genetic study into eating disorders, calling on […]
MoreMedical and Science
What powers GenesisCare’s bold path in cancer research: Clinical Trials Day
What does it take to deliver research that truly changes lives? For Sonya McColl, National Research Manager of Oncology at […]
MoreMedical and Science
Health and medical research at a crossroads: Sector calls for reform as 48th Parliament takes shape
Australia’s 48th Parliament opens the door to a generational shift in how the nation approaches research and development, beckoning reforms […]
MoreMedical and Science
Major political parties dismiss research sector warnings
Australia’s major political parties have failed to commit to critical reforms that could determine the survival of the nation’s health […]
MoreMedical and Science
The high cost of record low research funding
Australia has delivered some of the world’s most transformative health and medical breakthroughs – the cochlear implant, the HPV vaccine, […]
MoreMedical and Science
MTAA and ARCS welcome Innovation Blueprint
The NSW Government has unveiled the NSW Innovation Blueprint 2035, a strategic plan designed to solidify the state’s position as […]
MoreMedical and Science
Research on life support as government Budget fails to deliver critical funding
Stakeholders are voicing disappointment over the government’s Budget failure to at least maintain research funding in line with inflation. In […]
MoreMedical and Science
Political interference in Australian research rejected by universities
The federal government has been strongly urged to reject the Trump administration’s attempts to influence Australian research projects. Researchers involved […]
MoreMedical and Science
Largest-ever funding boosts local glaucoma research
The largest single philanthropic investment in glaucoma science has been launched in Australia. The Snow Medical Research Foundation has initiated […]
MoreRecent Posts in Pharma, MedTech & Biotech
NRF backs local ophthalmic biotech
May 30, 2025
in News & Trends - Biotechnology
Who’s accountable for Australia’s private hospital meltdown?
May 30, 2025
in News & Trends - MedTech & Diagnostics
Medicare-funded lifeline fuels community action in cardiovascular disease
May 30, 2025
in News & Trends - MedTech & Diagnostics
Growth hormone therapy gains TGA nod
May 30, 2025
in News & Trends - Pharmaceuticals
Medtech priorities for Labor’s second term: Time to deliver
May 28, 2025
in News & Trends - MedTech & Diagnostics
Shifting the curve: Long-term data redefines survival in metastatic prostate cancer
May 28, 2025
in News & Trends - Pharmaceuticals
Australia at a crossroads in obesity management: Experts call for strategic use of GLP-1 receptor agonists
May 28, 2025
in News & Trends - Pharmaceuticals
Scalpel meets the bottom line: Healthscope collapse spurs sector-wide call for reform
May 28, 2025
in News & Trends - MedTech & Diagnostics
Follow Us
Partner with us
News & Trends - Biotechnology
NRF backs local ophthalmic biotech
A Melbourne-based biotechnology company has landed a game-changing investment to push forward its novel glaucoma implant to address the long-standing […]
MoreNews & Trends - MedTech & Diagnostics
Who’s accountable for Australia’s private hospital meltdown?
Private hospitals across Australia are facing an unprecedented viability crisis, one that healthcare leaders say has been worsened by profit-hungry […]
MoreNews & Trends - MedTech & Diagnostics
Medicare-funded lifeline fuels community action in cardiovascular disease
With the Medicare-funded Heart Health Check extension set to begin on 1 July 2025, advocates are recognising the significance of […]
MoreNews & Trends - Pharmaceuticals
Growth hormone therapy gains TGA nod
The Therapeutic Goods Administration (TGA) has approved a new growth hormone deficiency (GHD) treatment for children and adolescents, expanding options […]
More